Synopsis of recent research by authors named "Ana Mitrovic"
- Ana Mitrovic's recent research primarily focuses on the therapeutic potential of cathepsins and Hsp90 inhibitors in cancer treatment, highlighting their roles in tumor progression and responses in various diseases such as triple-negative breast cancer and SARS-CoV-2 infections.
- Her studies have identified and optimized novel compounds, such as cathepsin V inhibitors and Hsp90 C-terminal domain inhibitors, demonstrating their capability to impair tumor cell proliferation while enhancing immune responses against cancer cells.
- Mitrovic's work also involves investigating the compensatory roles of lysosomal peptidases, particularly cathepsins, suggesting their complex involvement in maintaining cellular homeostasis and influencing cancer and inflammatory diseases, alongside developing innovative multi-target drugs.
